Key result
Ambulatory blood pressure monitoring yielded significantly lower mean systolic blood pressure compared to clinic measurements in Stage V chronic kidney disease patients (129.52 vs 136.53 mmHg, p<0.001).
Why the study?
Hypertension leads to rapid CKD progression, and ambulatory blood pressure monitoring can aid in accurate, early diagnosis and assessment of blood pressure patterns.
Does 24-h Ambulatory Blood Pressure Monitoring (ABPM) provide different blood pressure measurements and clinical insights compared to clinic blood pressure measurement in hospitalized patients with Chronic Kidney Disease?
Observational (n=192)
No
Does 24-h Ambulatory Blood Pressure Monitoring (ABPM) provide different blood pressure measurements and clinical insights compared to clinic blood pressure measurement in hospitalized patients with Chronic Kidney Disease?
Answers are grounded in this paper and cite their sources.
ABPM reveals a high prevalence of non-dipping patterns, masked hypertension, and resistant hypertension in CKD patients, demonstrating that clinic BP alone overestimates daytime BP and misses critical nocturnal risk factors.
INTRODUCTION: Hypertension leads to rapid progression of kidney disease. Hypertension (HTN) is the second most common cause for CKD after diabetes. Ambulatory blood pressure monitoring (ABPM) helps in accurate and early diagnosis of HTN along with measurements of other variables, namely nondippers, reverse dippers, hyperbaric index (HBI), percentage time elevation (PTE), and early morning surge. METHODOLOGY: After obtaining the institution ethics committee approval total 192 cases, of 12-80 years age group, who were diagnosed with CKD were included in the study. ABPM was done for patients using Meditech ABPM-05 machine. RESULTS: Study showed male predominance. Maximum patients were in the age group of 41-60 years. Prevalence of Hypertension in patients with CKD was 88.02%. The systolic BP, diastolic BP, and mean arterial pressure (MAP) were significantly higher by clinic BP measurement than ABPM in all stages of patients with CKD especially in stage IV than stage V CKD. Systolic, diastolic, MAP, HBI and PTE at nighttime were significantly higher than daytime in all patients with CKD, especially in patients with resistant hypertension. Prevalence of whitecoat HTN (4.1%), whitecoat effect (16.1%), resistant hypertension (39.6%), masked HTN (1%), and masked uncontrolled HTN (10.4%) was noted. Systolic and diastolic HBI was lower in patients on hemodialysis as compared to those not on hemodialysis. Non-dippers were more than dippers. CONCLUSION: Apart from mean systolic and diastolic BP, ABPM gives the extent of end-organ damage and insights into the need for control of 24 h BP in patients of CKD.
No takes yet. Share an insight, caveat, or question.
Salagre et al. (2021) conducted an observational in Chronic Kidney Disease (n=192). Ambulatory Blood Pressure Monitoring vs. Clinic Blood Pressure was evaluated on Systolic blood pressure in Stage V CKD patients (p=<0.001). Ambulatory blood pressure monitoring yielded significantly lower mean systolic blood pressure compared to clinic measurements in Stage V chronic kidney disease patients (129.52 vs 136.53 mmHg, p<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: